Christopher Bird
Christopher Bird has been appointed CMO of Danish IVD firm BioPorto, effective Aug. 1. He was previously at Roche Diagnostics where he headed the North American Medical and Scientific Affairs organization. At BioPorto, he will be responsible for building, executing, and overseeing the company's diagnostic product development strategy.